WTB
KYNB

Washington Trust Bank’s Kyntra Bio KYNB Stock Holding History

Washington Trust Bank’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10
Closed -$5K – 830
2016
Q1 		$5K Buy
10
+4
+67% +$1.99K ﹤0.01% 640
2015
Q4 		$5K Buy
+6
New +$3.98K ﹤0.01% 653

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Washington Trust Bank's KYNB Position: Q2 2016 in Review

Washington Trust Bank sold out of Kyntra Bio (KYNB) in Q2 2016, closing a stake of 10 shares — an estimated $5K sold.

Washington Trust Bank first reported a position in KYNB in Q4 2015 and held it in 2 quarters. The position peaked at $5K in Q1 2016. 146 funds tracked by Wall St. Rank hold KYNB as of Q2 2016.

  • Washington Trust Bank reported no remaining Kyntra Bio position as of Q2 2016 after selling out during the quarter.
  • Washington Trust Bank sold 10 Kyntra Bio shares in Q2 2016, an estimated $5K.
  • Washington Trust Bank first reported a position in Kyntra Bio in Q4 2015 and held it in 2 quarters.
  • Washington Trust Bank's Kyntra Bio position peaked at $5K in Q1 2016.
  • 146 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2016.

Based on Washington Trust Bank's 13F filing for Q2 2016, filed 7 Jul 2016.